1. Home
  2. RGCO vs CERS Comparison

RGCO vs CERS Comparison

Compare RGCO & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RGC Resources Inc.

RGCO

RGC Resources Inc.

N/A

Current Price

$22.50

Market Cap

232.9M

Sector

Utilities

ML Signal

N/A

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$1.92

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGCO
CERS
Founded
1912
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
EDP Services
Sector
Utilities
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
232.9M
276.0M
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
RGCO
CERS
Price
$22.50
$1.92
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
8.8K
1.4M
Earning Date
11-19-2025
11-06-2025
Dividend Yield
3.62%
N/A
EPS Growth
11.26
N/A
EPS
1.29
N/A
Revenue
$95,334,212.00
$199,191,000.00
Revenue This Year
$9.00
$25.31
Revenue Next Year
$8.30
$9.50
P/E Ratio
$17.78
N/A
Revenue Growth
12.63
13.03
52 Week Low
$19.06
$1.12
52 Week High
$23.82
$2.24

Technical Indicators

Market Signals
Indicator
RGCO
CERS
Relative Strength Index (RSI) 57.28 58.88
Support Level $21.86 $1.81
Resistance Level $22.42 $2.14
Average True Range (ATR) 0.59 0.13
MACD 0.01 0.01
Stochastic Oscillator 75.37 62.70

Price Performance

Historical Comparison
RGCO
CERS

About RGCO RGC Resources Inc.

RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: